16+
Major trials tracked
GLP-1 & incretin therapies · Live ClinicalTrials.gov data
Dulaglutide (Trulicity) clinical trial pipeline
The timeline below tracks the 16 largest phase 2–4 dulaglutide trials on ClinicalTrials.gov by enrolment. Refreshed daily — add up to four competitors to compare pipelines side by side.
13
Phase 3 trials
0
Actively recruiting
33,510
Participants across trials
Eli Lilly and Company
Lead sponsor by trial count
dulaglutide (16)2 active2010–2027
dulaglutide
'10
'12
'14
'16
'18
'20
'22
'24
'26
dulaglutide
A Study in Participants With Type 2 Diabetes Mellitus (AWARD-3)P3
A Study of the Effect of LY2189265 on Blood Pressure and Heart Rate in Type 2 DiabetesP2
REWINDP3
A Study of LY2189265 in Japanese Participants With Type 2 Diabetes MellitusP3
LixiLan-GP3
PIONEER 10P3
AWARD-11P3
AMPLITUDE-DP3
SURPASS J-monoP3
SURPASS-CVOTP3
AWARD-JPNP3
A Study of LY3502970 in Participants With Type 2 Diabetes MellitusP2
A Study of IBI362 in Participants With Type 2 DiabetesP3
A Phase 3 Study to Evaluate the Efficacy of XW003 Compared With Dulaglutide in Participants With T2DMP3
A Study of TG103 Injection Combined With Metformin in Treatment of Type 2 Diabetes MellitusP3
Real-World Evaluation of Omarigliptin for Type 2 Diabetes Meliitus in BangladeshP4
Upcoming readouts
dulaglutide
No shown trials have a primary-completion date after today.
Select a trial to load its full ClinicalTrials.gov record.
Key dulaglutide trials
Top 12 of the 16 tracked phase 2–4 trials, ordered by phase and status. Each links to its full ClinicalTrials.gov record.
| Trial | Title | Phase | Status | Primary completion |
|---|---|---|---|---|
| NCT06449235 | Real-World Evaluation of Omarigliptin for Type 2 Diabetes Meliitus in Bangladesh | Phase 4 | Not yet recruiting | Apr 2025 |
| NCT01126580 | A Study in Participants With Type 2 Diabetes Mellitus (AWARD-3) | Phase 3 | Completed | Nov 2011 |
| NCT01558271 | A Study of LY2189265 in Japanese Participants With Type 2 Diabetes Mellitus | Phase 3 | Completed | Oct 2013 |
| NCT02787551 | LixiLan-G — Efficacy and Safety of the Insulin Glargine/Lixisenatide Fixed Ratio Combination (FRC) Versus GLP-1 Receptor A… | Phase 3 | Completed | May 2018 |
| NCT03015220 | PIONEER 10 — Safety and Efficacy of Oral Semaglutide Versus Dulaglutide Both in Combination With One OAD (Oral Antidiabetic… | Phase 3 | Completed | Jul 2018 |
| NCT01394952 | REWIND — Researching Cardiovascular Events With a Weekly Incretin in Diabetes (REWIND) | Phase 3 | Completed | Aug 2018 |
| NCT03495102 | AWARD-11 — A Study of the Efficacy and Safety of Dulaglutide (LY2189265) in Participants With Type 2 Diabetes | Phase 3 | Completed | May 2019 |
| NCT03861052 | SURPASS J-mono — A Study of Tirzepatide (LY3298176) Compared to Dulaglutide in Participants With Type 2 Diabetes | Phase 3 | Completed | Mar 2021 |
| NCT04809220 | AWARD-JPN — A Study of Two Doses of Dulaglutide (LY2189265) in Japanese Patients With Type 2 Diabetes | Phase 3 | Completed | Oct 2022 |
| NCT05606913 | A Study of IBI362 in Participants With Type 2 Diabetes | Phase 3 | Completed | Jan 2024 |
| NCT05680129 | A Phase 3 Study to Evaluate the Efficacy of XW003 Compared With Dulaglutide in Participants With T2DM | Phase 3 | Completed | Jul 2024 |
| NCT04255433 | SURPASS-CVOT — A Study of Tirzepatide (LY3298176) Compared With Dulaglutide on Major Cardiovascular Events in Participants Wi… | Phase 3 | Completed | Jun 2025 |
Related drug pipelines
FAQ
- How many clinical trials are running for dulaglutide?
- ClinicalTrials.gov lists more than 16 phase 2–4 dulaglutide trials. This page tracks the 16 largest by enrolment: 2 phase 2, 13 phase 3, and 1 phase 4 among them, with 0 actively recruiting. Updated daily.
- Where does this data come from?
- All trial data is sourced from ClinicalTrials.gov (CTGov) and refreshed on this page daily.
- Can I compare dulaglutide against other drugs?
- Yes. The free ComplyRx Trial Pipeline tool compares up to five drugs side by side on one timeline, with PNG and PDF export. Add any competitor in the search box above.
Join the waitlist
Be the first to access ComplyRx
We'll let you know as soon as your spot opens to use ComplyRx.
By joining, you agree to our Privacy Policy.